Un Characterized AarF Domain-Containing Protein Kinase 4 (COQ8B): A Potential Drug Target and Biomarker

Target Name: COQ8B

NCBI ID: G79934

COQ8B

Un Characterized AarF Domain-Containing Protein Kinase 4 (COQ8B): A Potential Drug Target and Biomarker

Introduction

Uncharacterized AarF domain-containing protein kinase 4 (COQ8B) is a protein that has been identified in various cellular pathways. It plays a crucial role in the regulation of cell growth, apoptosis, and metabolism. The identification of COQ8B as a potential drug target and biomarker has significant implications for the development of new therapeutic strategies.

Molecular Background

COQ8B is a protein that belongs to the AarF domain family, which is characterized by the presence of a specific domain called AarF. This domain is known to be involved in protein-protein interactions and is involved in various cellular processes, including cell signaling, DNA replication, and metabolism. The AarF domain is a conserved region that is found in various proteins, including COQ8B.

Expression and Localization

COQ8B is expressed in various cell types, including neurons, muscle cells, and cancer cells. It is predominantly expressed in the cytoplasm and is localized to the endoplasmic reticulum (ER) and the nuclear envelope (NE). COQ8B is also known to be involved in the regulation of cellular processes, including cell growth, apoptosis, and metabolism.

Drug Target Potential

The AarF domain is known to be involved in protein-protein interactions, which suggests that COQ8B may be a drug target. The potential targets of COQ8B may include other proteins that are involved in cell signaling pathways, such as kinases, inhibitors, regulators wait. By inhibiting COQ8B activity, it is possible to block cell signaling pathways, thereby inhibiting the growth and spread of tumor cells. In addition, COQ8B may also be a target for drugs that target the endoplasmic reticulum and the nuclear envelope, as these structures are known to be involved in the regulation of cellular processes.

Biomarker Potential

The expression of COQ8B and its localization to the endoplasmic reticulum and the nuclear envelope suggest that it may be a biomarker for various diseases, including cancer. The levels of COQ8B expression may be used as a diagnostic marker for cancer, as high levels of COQ8B expression are often associated with cancer. Additionally, the regulation of COQ8B activity may be involved in the development and progression of various diseases, including cancer.

Conclusion

In conclusion, COQ8B is a protein that has been identified in various cellular pathways and is involved in the regulation of cell growth, apoptosis, and metabolism. Its expression and localization to the endoplasmic reticulum and the nuclear envelope suggest that it may be a potential drug target and biomarker. Further research is needed to determine the full potential of COQ8B as a drug target and biomarker.

Protein Name: Coenzyme Q8B

Functions: Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:24270420). Its substrate specificity is unclear: does not show any protein kinase activity. Probably acts as a small molecule kinase, possibly a lipid kinase that phosphorylates a prenyl lipid in the ubiquinone biosynthesis pathway. Required for podocyte migration (PubMed:24270420)

The "COQ8B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COQ8B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets